Approval · Notice of Compliance 2885 · 2004
PROMETRIUM: Notice of Compliance 2885
Issued May 13, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2885
- Date
- May 13, 2004
- Company
- Schering Canada Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph update resulting from the women's health initiative (whi) study
- Therapeutic class
- Progestin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROMETRIUM | Not yet assigned | — |
Medicinal ingredients
- PROGESTERONE 100 MG per CAP